Nourhan S. Elkholy, Mohamad Louai M. Hariri, Haitham S. Mohammed, Medhat W. Shafaa
{"title":"游离和纳米分散形式的叶黄素和β-胡萝卜素的抗氧化活性和细胞毒性表征","authors":"Nourhan S. Elkholy, Mohamad Louai M. Hariri, Haitham S. Mohammed, Medhat W. Shafaa","doi":"10.1007/s12247-023-09745-2","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose</h3><p>Carotenoids are potent natural antioxidants with many important applications. Their nanodispersion formulations can solve problems that may limit their usage. In this study, we produced carotenoid nanodispersions from extracted lutein (nano-Lut), extracted β-carotene (nano-EBc), and synthetic β-carotene (nano-SBC).</p><h3>Methods</h3><p>The present study has quantitatively emphasized the physicochemical, antioxidant, and cytotoxic properties of free and nanodispersed formulations of lutein and β-carotene. The nanodispersions were characterized by spectral absorption, dynamic light scattering, and zeta potential. Antioxidant and cytotoxicity assays were conducted for free and their nanodispersed forms. The cytotoxicity of free carotenoids and their nanodispersions was conducted on HSF, VERO, and BNL cell lines.</p><h3>Results</h3><p>Nano-Lut has the smallest mean particle size (185.2 ± 40.5 nm, PDI of 0.183 ± 0.01, and zeta potential of −28.6 ± 6.4 mV). Nano-SBc showed monomodal size distribution (220.5 ± 30.09 nm, PDI of 0.318 ± 0.03, and zeta potential of −12.1 ± 5.9 mV), while nano-EBc showed a bimodal size distribution (with a mean particle size of 498.3 ± 88.9 nm, PDI of 0.65 ± 0.08, and zeta potential of −39.7 ± 1.3 mV). All prepared nanodispersions showed less than 20% loss during the formulation process. Antioxidant assays showed that extracted lutein was the most active and synthetic β-carotene was the least. Cells showed higher tolerance for lutein and its nanodispersion than extracted or synthetic β-carotene either in free or nanodispersion forms.</p><h3>Conclusions</h3><p>The study proved that lutein in nanodispersed form possesses the smallest size, the highest antioxidant activity, and the lowest cytotoxicity among the tested formulations.\n</p></div>","PeriodicalId":656,"journal":{"name":"Journal of Pharmaceutical Innovation","volume":"18 4","pages":"1727 - 1744"},"PeriodicalIF":2.7000,"publicationDate":"2023-07-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s12247-023-09745-2.pdf","citationCount":"0","resultStr":"{\"title\":\"Lutein and β-Carotene Characterization in Free and Nanodispersion Forms in Terms of Antioxidant Activity and Cytotoxicity\",\"authors\":\"Nourhan S. Elkholy, Mohamad Louai M. Hariri, Haitham S. Mohammed, Medhat W. Shafaa\",\"doi\":\"10.1007/s12247-023-09745-2\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Purpose</h3><p>Carotenoids are potent natural antioxidants with many important applications. Their nanodispersion formulations can solve problems that may limit their usage. In this study, we produced carotenoid nanodispersions from extracted lutein (nano-Lut), extracted β-carotene (nano-EBc), and synthetic β-carotene (nano-SBC).</p><h3>Methods</h3><p>The present study has quantitatively emphasized the physicochemical, antioxidant, and cytotoxic properties of free and nanodispersed formulations of lutein and β-carotene. The nanodispersions were characterized by spectral absorption, dynamic light scattering, and zeta potential. Antioxidant and cytotoxicity assays were conducted for free and their nanodispersed forms. The cytotoxicity of free carotenoids and their nanodispersions was conducted on HSF, VERO, and BNL cell lines.</p><h3>Results</h3><p>Nano-Lut has the smallest mean particle size (185.2 ± 40.5 nm, PDI of 0.183 ± 0.01, and zeta potential of −28.6 ± 6.4 mV). Nano-SBc showed monomodal size distribution (220.5 ± 30.09 nm, PDI of 0.318 ± 0.03, and zeta potential of −12.1 ± 5.9 mV), while nano-EBc showed a bimodal size distribution (with a mean particle size of 498.3 ± 88.9 nm, PDI of 0.65 ± 0.08, and zeta potential of −39.7 ± 1.3 mV). All prepared nanodispersions showed less than 20% loss during the formulation process. Antioxidant assays showed that extracted lutein was the most active and synthetic β-carotene was the least. Cells showed higher tolerance for lutein and its nanodispersion than extracted or synthetic β-carotene either in free or nanodispersion forms.</p><h3>Conclusions</h3><p>The study proved that lutein in nanodispersed form possesses the smallest size, the highest antioxidant activity, and the lowest cytotoxicity among the tested formulations.\\n</p></div>\",\"PeriodicalId\":656,\"journal\":{\"name\":\"Journal of Pharmaceutical Innovation\",\"volume\":\"18 4\",\"pages\":\"1727 - 1744\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2023-07-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://link.springer.com/content/pdf/10.1007/s12247-023-09745-2.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Pharmaceutical Innovation\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://link.springer.com/article/10.1007/s12247-023-09745-2\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmaceutical Innovation","FirstCategoryId":"3","ListUrlMain":"https://link.springer.com/article/10.1007/s12247-023-09745-2","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
Lutein and β-Carotene Characterization in Free and Nanodispersion Forms in Terms of Antioxidant Activity and Cytotoxicity
Purpose
Carotenoids are potent natural antioxidants with many important applications. Their nanodispersion formulations can solve problems that may limit their usage. In this study, we produced carotenoid nanodispersions from extracted lutein (nano-Lut), extracted β-carotene (nano-EBc), and synthetic β-carotene (nano-SBC).
Methods
The present study has quantitatively emphasized the physicochemical, antioxidant, and cytotoxic properties of free and nanodispersed formulations of lutein and β-carotene. The nanodispersions were characterized by spectral absorption, dynamic light scattering, and zeta potential. Antioxidant and cytotoxicity assays were conducted for free and their nanodispersed forms. The cytotoxicity of free carotenoids and their nanodispersions was conducted on HSF, VERO, and BNL cell lines.
Results
Nano-Lut has the smallest mean particle size (185.2 ± 40.5 nm, PDI of 0.183 ± 0.01, and zeta potential of −28.6 ± 6.4 mV). Nano-SBc showed monomodal size distribution (220.5 ± 30.09 nm, PDI of 0.318 ± 0.03, and zeta potential of −12.1 ± 5.9 mV), while nano-EBc showed a bimodal size distribution (with a mean particle size of 498.3 ± 88.9 nm, PDI of 0.65 ± 0.08, and zeta potential of −39.7 ± 1.3 mV). All prepared nanodispersions showed less than 20% loss during the formulation process. Antioxidant assays showed that extracted lutein was the most active and synthetic β-carotene was the least. Cells showed higher tolerance for lutein and its nanodispersion than extracted or synthetic β-carotene either in free or nanodispersion forms.
Conclusions
The study proved that lutein in nanodispersed form possesses the smallest size, the highest antioxidant activity, and the lowest cytotoxicity among the tested formulations.
期刊介绍:
The Journal of Pharmaceutical Innovation (JPI), is an international, multidisciplinary peer-reviewed scientific journal dedicated to publishing high quality papers emphasizing innovative research and applied technologies within the pharmaceutical and biotechnology industries. JPI''s goal is to be the premier communication vehicle for the critical body of knowledge that is needed for scientific evolution and technical innovation, from R&D to market. Topics will fall under the following categories:
Materials science,
Product design,
Process design, optimization, automation and control,
Facilities; Information management,
Regulatory policy and strategy,
Supply chain developments ,
Education and professional development,
Journal of Pharmaceutical Innovation publishes four issues a year.